Tips on Selecting the Best Pharma PCD Company

Starting a pharma franchise comes with many challenges, including finding the best company to partner with. Finding the best pharma PCD company can be daunting unless you do extensive research. However, you do not have to spend too much time on that. To help reduce your guesswork, we listed tips to help you make an informed choice.

Decide what to sell

Pharmaceutical companies differ in the range of products they offer. Some of the best specialise in ayurvedic goods, which are in high demand in India. Just be sure the company is well-known to Ayurveda practitioners and trusted by many customers across the country.

Know the company and its reputation

Browsing pharma PCD companies can introduce a range of names to you. Narrow the selection to established and reputable brands with professional names that are easy to recall and associate with the products. Verify the company’s reputation in its industry to ensure its credibility, trustworthiness, and quality of its goods and services.

Explore the product range

The best pharma PCD company can provide a list of its products online. Request a price list from your prospects to compare their offerings and determine which business has the product range you’re considering. Ensure high-quality, attractive packaging and help your business make the best impression on patients, doctors, and chemists.

Verify stock availability and the procurement process

A complete inventory can help your business succeed, so ensure the company can provide a regular supply of the products you want to sell. Ensure the timely procurement and delivery of goods, especially if you plan to open your franchise in far-off villages or small towns. Some of the best companies provide same-day dispatch with live order tracking.

See samples of the promotional materials.

The best pharma PCD company offers high-quality promotional materials and marketing aids like prescription pads, visual aids, reminder cards, keychains, gifts, and more at no additional cost.

Ensure monopoly and affordable payments

Choose a pharma PCD company that provides monopoly rights to reduce competition. Payment terms and conditions must be stated clearly from the start. Some companies may even allow partial payment to help you start sooner, and then you can pay the rest in instalments.

Choose the Best Franchise Pharma Products for Your Company

Perhaps you have found the best pharma PCD company, but it’s not enough to partner with an outstanding business for your franchise. You also need to carefully select franchise pharma products to ensure your long-term growth and success. Here are tips to help you with that.

Research

Conduct market research to gauge the level of competition and the health needs of your target consumers. It will also allow you to understand your market and its demands, trends, and other things that matter when planning your product selection.

Decide on a budget

Financial planning is crucial to every business, especially for a pharma franchise. Discuss the costs with the company to know how much money to invest in its products. However, don’t let a limited or low budget prevent you from choosing more products. Some companies can work with you to plan your expenses and offer reasonable instalment plans.

Explore the market trends

Study the market trends before investing too much in certain products to reduce risk. Look into prevailing ones to help you pick the best franchise pharma products that are likely to be in demand in your chosen location. This is also an excellent point to create business strategies and a marketing plan to help you make the most of the trends. That way, you can meet the needs of your customers.

Get to know the existing products in your market. Sometimes, you will find goods with long-standing hype that makes them continuously popular. Knowing this, you can consider unique and innovative goods with the potential to be better.

Ensure high-quality packaging

Product packaging is crucial as it is the first thing customers will notice. Choose franchise pharma products with unique and attractive packaging to preserve their quality and ensure durability and longevity. You should also ensure the quality of the goods. Verify that they are manufactured in GMP-certified facilities.

How is PCD Pharma Growing in India in 2023? | Vibcare Pharma

Every entrepreneur dreams of launching a successful business that can make a lot of money. Success depends on how hard one works, along with other factors, such as the demand for products, high-quality goods, and services. One of the growing business ventures in India is PCD pharma. The sector is currently worth over 40 billion dollars. It is expected to exceed 100 billion dollars in the next few years as it continues to thrive and attract more budding and experienced entrepreneurs looking for more opportunities to make a profit.

Today, many new entrepreneurs are jumping into the market with a propaganda-cum-distribution pharma franchise business model. As such, it is considered the backbone of India’s pharmaceutical industry.

Continuous growth from 2023 and beyond

Many factors are contributing to the success of pharma franchise businesses in India. One of these is the low upfront investment, which allows entrepreneurs to start, even with minimal income. Then, as their business thrives, they can gradually expand it.

PCD pharma franchise businesses are also popular in India for providing higher profit margins. With the increasing demand for pharmaceutical products, the scope for more profits never ends. Many companies are getting sufficient ROI with a lower risk, and franchisees can make their own decisions, enabling more control over the business while being supported by the franchisor.

Meeting the demand for high-quality pharma products.

Some PCD pharma franchises can do better than others, such as those selling Ayurvedic products. During the COVID-19 pandemic, emphasis was given to disease prevention and the importance of better immunity, driving further interest in Ayurveda to achieve those objectives.

Entrepreneurs who work with a PCD pharma franchise can provide Ayurvedic products and medicines to their select areas while having a monopoly in their chosen market. They can also offer the goods to small villages and towns, which may otherwise not have easier access to state-of-the-art treatments and preventive medicines.

 

Things you should know about pharma PCD Franchise Company

It is never easy to find a proper pharma PCD franchise company without doing research. Here are some guidelines that you need to look for when you search for a PCD franchise company. (more…)

Why is PCD Pharma suppliers Business More Profitablethan Others

If you wish to begin a profitable business opportunity, then you should opt to become one amongst the PCD pharma suppliers. Regardless of the economic condition in the country, this particular industry is deemed (more…)

Why Third-Party Manufacturing Took Over Indian Pharma: 3 Structural Reasons

Twenty years ago, a pharmaceutical company in India owned a plant. Today most of them do not, and the ones selling the most medicine are often the ones manufacturing the least of it themselves. That shift did not happen because someone had an idea. It happened because of three specific pressures — and understanding them tells you more about how this industry works than any brochure will.

For the mechanics, read how third-party manufacturing works. This page is about why it took over.

1. Compliance got expensive, and it never stops costing

Schedule M and WHO-GMP norms turned a factory from a shed with machines into a validated, documented, permanently inspection-ready operation. Clean rooms, HVAC, water systems, stability chambers, a QC lab, qualified persons, documentation.

The important part is that this cost is fixed and continuous. It runs whether you produced anything that month or not. A brand owner selling ₹50 lakh a month cannot carry that. A manufacturer running several companies' batches through the same validated line can carry it comfortably — because the same compliance overhead is spread across everybody's production.

That single economic fact created the contract manufacturing industry.

2. Regulation forced specialisation by dosage form

You cannot legally make everything in one building. Beta-lactam antibiotics require physically segregated premises. Ophthalmics and injectables need sterile lines. Ayurvedic products are licensed under an entirely separate Act.

So a company wanting to sell tablets, an antibiotic, an eye drop and an injectable is not contemplating one factory. It is contemplating four sets of premises, four validation programmes, four licences. Almost nobody builds that. They build one, and outsource the rest — which is why even large manufacturers are themselves customers of other manufacturers.

Specialisation was not a business choice. Regulation made it structural.

3. The PCD model created thousands of brand owners with no plant

The PCD franchise system put pharmaceutical distribution into the hands of thousands of small operators across Tier 2 and Tier 3 India — people with doctor relationships and territory knowledge, and no interest whatsoever in owning a factory.

Every one of them needed products under a brand. None of them were going to manufacture. That demand had to land somewhere, and it landed on contract manufacturers. The growth of third-party manufacturing and the growth of PCD franchise are the same story told from two ends.

What actually changed: risk moved

Third-party manufacturing did not make medicine cheaper to produce. It moved where the risk sits. Capital risk, idle-capacity risk and compliance risk moved to the manufacturer, who can spread them across many customers. Market risk — will this product sell — stayed with the brand owner, who is the only one who can influence it.

That is a genuinely efficient arrangement, and it is why it won. Each party carries the risk it can actually manage.

What it means for you

Mostly this: the plant making your medicine is probably not owned by the company whose name is on the box. That is normal and it is legal. It only becomes a problem when nobody will tell you which plant it is.

Which is why the useful question was never "do you have WHO-GMP." It is: which site, at what address, certified for which dosage forms, under which licence number. The industry grew up around outsourcing. The only thing that separates companies now is whether they are straight about it.

Who manufactures for Vibcare

Vibcare Pharma is a PCD pharma franchise company. It does not manufacture. Manufacturing is done by Vibcare Healthcare Private Limited — a separate company under the same ownership, with its own plant, licences and website.

The site: Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana. WHO-GMP certified by the State Drugs Controller-cum-Licensing Authority, FDA Haryana. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024. Licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. 100,000 sq ft clean room, 750+ drug approvals.

Certified for four dosage forms: tablets, capsules and external preparations — all non beta-lactam — and oral liquids. It does not make beta-lactam antibiotics, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays, protein powders and sachets, or ayurvedic products, because it is not certified for them — which is reason 2 on this page, happening to us.

Looking for the manufacturing side?

Vibcare Healthcare is the manufacturing company — WHO-GMP certified, 100,000 sq ft clean room, 750+ drug approvals, all certificates published in full on its own site. Tablets, capsules, oral liquids and external preparations.

See Vibcare Healthcare's third-party manufacturing services →
Inside the facility  ·  Request a quote  ·  Call +91 8566076607

Interested in the other end of this story? A PCD pharma franchise is reason 3 in practice — a monopoly territory selling an existing brand range, from ₹25,000, with no plant to build. Here is the difference.

Frequently asked questions

Why has third-party manufacturing grown in India?

Three reasons. Compliance became a large fixed cost that only makes sense spread across many customers' production. Regulation forces different dosage forms into different premises, so no single plant covers a broad range. And the PCD franchise model created thousands of brand owners who never intended to own a factory.

Why do pharma companies not own their own plants?

Because a compliant plant costs crores in capital plus a permanent compliance and QC team, and it loses money whenever it runs below capacity. Contract manufacturing converts that fixed cost into a per-batch cost, so capital goes into stock and market building instead of fixed assets.

Is third-party manufacturing legal in India?

Yes. The product is manufactured under the manufacturer's drug licence, at their certified premises, and packed under the brand owner's name. The manufacturing licence number and site address are printed on every pack. It is how a large share of medicine sold in India is legitimately produced.

Will third-party manufacturing keep growing?

The pressures behind it have not reversed. Compliance costs are rising, not falling; dosage-form segregation is regulation; and the PCD model continues to add brand owners with no manufacturing intent. The structural logic that created the industry is still fully intact.

Benefits of PCD Franchise for the Indian Pharmaceutical Market

As the demand for healthcare facilities and medicines has globally increased, several young aspirants are looking to make a career in the pharma industry. It is one of the rising sectors in the whole country that provides good opportunities (more…)

Points to consider before choosing the right Ayurvedic Medicine

Following the latest trends in the pharmaceutical industry, seeking an ayurvedic franchise is the ideal plan to set a business. For this, you will have to choose the right ayurvedic medicine PCD company with a diverse product range. (more…)

Third-Party vs Contract vs Loan Licensing vs CDMO: What the Terms Actually Mean

Third-party manufacturing. Contract manufacturing. Loan licensing. P2P. CDMO. Toll manufacturing. In Indian pharma these get used as if they mean the same thing, and they mostly do — except when they do not, and the difference decides whose licence your product is made under and who carries the blame if a batch fails.

Here is what each term actually means, in practice, in this industry.

Third-party manufacturing

The everyday Indian term. A licensed manufacturer produces medicine for you, at their plant, under their drug licence, packed under your brand. Their licence number and site address are printed on your pack.

You own the brand and the market. They own the plant, the licence, the compliance and batch quality. This is what most people mean by every term on this page, and it is what most of the industry actually runs on.

Contract manufacturing

The formal term for the same arrangement. If someone says contract manufacturing and someone else says third-party manufacturing, in India they are almost always describing the identical thing. Contract manufacturing tends to be used for larger, longer arrangements and in international contexts; third-party is what people say on the phone.

Loan licensing — this one is genuinely different

Here the arrangement inverts. Under a loan licence, you hold a manufacturing licence for a plant you do not own — you borrow the facility. The product is made on your licence, using their premises and equipment.

The practical consequence: the regulatory responsibility is yours, not theirs. Under third-party manufacturing, the manufacturer's site certificate makes batch quality their obligation. Under a loan licence, you hold the licence, so you hold the exposure.

Most people asking for "third-party manufacturing" do not want a loan licence and should not agree to one by accident. Ask which arrangement you are actually signing.

P2P (principal-to-principal)

A commercial framing rather than a regulatory one. Both parties deal as independent businesses: they sell you finished goods, you buy them. It usually describes the same physical arrangement as third-party manufacturing, with the emphasis on a clean sale rather than a service.

Toll manufacturing

Strictly, the customer supplies the raw material and pays the manufacturer a "toll" to convert it. In Indian pharma the manufacturer almost always sources the API, so true toll arrangements are uncommon — the term gets borrowed loosely for contract manufacturing generally.

CDMO

Contract Development and Manufacturing Organisation. The difference is the D. A CDMO does not only make what you specify — it develops the formulation, runs the analytical work, does the stability studies, and then manufactures. If you have a molecule and no formulation, you want development. If you want a known combination made under your brand, you want plain contract manufacturing, and paying for CDMO capability is paying for something you will not use.

PCD franchise — not manufacturing at all

Included because it is constantly confused with the rest. In a PCD pharma franchise you do not own a brand and do not commission production. You sell an existing company's brands in a monopoly territory. No batch, no trademark, no artwork, no forecast.

Manufacturing suits people building their own brand. Franchise suits people who want to start selling without creating products. Many operators do both — franchise for breadth, own brands on their strongest molecules.

The only distinction that changes your risk

Ignore the vocabulary. Ask one question: whose drug licence is my product manufactured under?

Everything else on this page is vocabulary. That question is the arrangement.

Who manufactures for Vibcare

Vibcare Pharma is a PCD pharma franchise company. It does not manufacture. Manufacturing is done by Vibcare Healthcare Private Limited — a separate company under the same ownership, with its own plant, licences and website.

The site: Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana. WHO-GMP certified by the State Drugs Controller-cum-Licensing Authority, FDA Haryana. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024. Licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. 100,000 sq ft clean room, 750+ drug approvals.

Certified for four dosage forms: tablets, capsules and external preparations — all non beta-lactam — and oral liquids. It does not make beta-lactam antibiotics, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays, protein powders and sachets, or ayurvedic products, because it is not certified for them.

Whose licence? Ours. Here is the number.

Vibcare Healthcare is the manufacturing company — WHO-GMP certified, 100,000 sq ft clean room, 750+ drug approvals, all certificates published in full on its own site. Tablets, capsules, oral liquids and external preparations.

See Vibcare Healthcare's third-party manufacturing services →
Inside the facility  ·  Request a quote  ·  Call +91 8566076607

Want the franchise route instead? A PCD pharma franchise — monopoly territory, ready range, from ₹25,000, no manufacturing arrangement of any kind. Here is the difference.

Frequently asked questions

What is 3rd party manufacturing in the pharmaceutical industry?

An arrangement where a licensed manufacturer produces medicine at their plant, under their drug licence, packed under your brand name. Their licence number and site address appear on your pack. You own the brand and the market; they own the plant, the compliance and legal responsibility for batch quality.

What is the difference between third-party manufacturing and loan licensing?

In third-party manufacturing the product is made under the manufacturer's licence, so batch quality is legally their responsibility. Under a loan licence you hold a manufacturing licence for a plant you do not own, so the regulatory exposure is yours. Most people asking for third-party manufacturing should not sign a loan licence by accident.

Is contract manufacturing the same as third-party manufacturing?

In India, effectively yes. Contract manufacturing is the formal term, used more for larger or international arrangements; third-party manufacturing is what people say day to day. Both describe production at someone else's licensed plant under your brand name.

What is the difference between a CDMO and a contract manufacturer?

The D — development. A CDMO develops the formulation, runs analytical and stability work, then manufactures. A contract manufacturer makes a known formulation to your specification. If you have a molecule and no formulation you need development; if you want a known combination under your brand, you are paying for capability you will not use.

PCD pharma considered as one of the Best Business Options

The pharmaceutical industry in India is at its all-time high growth rate. The second most populated country generates a huge demand for pharmaceutical products. In fact, the increasing economy of India is also supporting (more…)